MagicTouch Brazil Approval: A Turning Point for Cardiovascular Innovation

São Paulo (Brazil), September 17: The Brazilian health sector has just experienced a turning point with the MagicTouch Brazil Approval from ANVISA, the health surveillance national authority. Concept Medical Group, the drug-delivery technology market leader, has obtained commercial approval for its lead Sirolimus-Coated Balloon (SCB) — MagicTouch — marking the first and sole device to be approved in Brazil for the treatment of coronary artery disease (CAD).

This achievement is not just a corporate win; it represents a change in…